This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Encompass Health (EHC) Unveils 40-Bed Hospital Plan in Ohio
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct an inpatient rehabilitation hospital in Ohio, which aims to facilitate improved rehabilitation services throughout the state.
Encompass Health (EHC) Boosts Texas Presence With Hospital Plan
by Zacks Equity Research
Encompass Health (EHC) aims to deliver better health outcomes by revealing plans to build an inpatient rehabilitation hospital in Texas.
Ensign Group (ENSG) Buys Facilities to Boost Real Estate Suite
by Zacks Equity Research
Ensign Group (ENSG) acquires five skilled nursing and assisted living facilities in three U.S. states. The move underscores ENSG's efforts to grow its real estate portfolio and boost U.S. presence.
Encompass Health (EHC) Set to Widen Presence in South Carolina
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.
Zacks.com featured highlights include: Celestica, Encompass Health, Atlas Corp, DXC Technology and Conn's
by Zacks Equity Research
Zacks.com featured highlights include: Celestica, Encompass Health, Atlas Corp, DXC Technology and Conn's
Pick These 5 Low P/CF Stocks to Garner Superior Returns
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Celestica (CLS), Encompass Health (EHC), Atlas (ATCO), DXC Technology (DXC) and Conn's (CONN) boast low P/CF ratio.
Encompass Health (EHC) Misses on Q3 Earnings, Cuts '21 EPS View
by Zacks Equity Research
Encompass Health's (EHC) third-quarter earnings miss estimates but improve year over year on the back of top-line growth resulting from a sound Inpatient Rehabilitation segment.
Encompass Health (EHC) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of -3.74% and -2.38%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Encompass Health (EHC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health
by Zacks Equity Research
Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health
Buy These 7 Best Value Stocks to Make the Most of P/B Ratio
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Walgreens (WBA) to Make Additional Investment in VillageMD
by Zacks Equity Research
Walgreens (WBA) announced a $5.2-billion investment in VillageMD to bolster its strategic position in delivering value-based primary care.
Encompass Health (EHC) Rides on Solid Revenues, Expansion Plans
by Zacks Equity Research
Encompass Health (EHC) continues to gain, courtesy of sustained growth in revenues, sound expansion endeavors across the United States and a robust 2021 business outlook.
LHC Group (LHCG) Finalizes Home Health & Hospice Buyout Deals
by Zacks Equity Research
LHC Group (LHCG) to expand in Virginia Beach with the completion of the previously announced acquisition agreements with two providers, one in home health and the other in hospice.
Zacks.com featured highlights include: Hibbett, Encompass Health, Berry Global Group, Vishay Intertechnology and Affiliated Managers Group
by Zacks Equity Research
Zacks.com featured highlights include: Hibbett, Encompass Health, Berry Global Group, Vishay Intertechnology and Affiliated Managers Group
Pick These 5 Low P/CF Stocks for a Value-Based Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Hibbett (HIBB), Encompass Health (EHC), Berry Global (BERY), Vishay Intertechnology (VSH) and Affiliated Managers (AMG) boast low P/CF ratio.
Should Value Investors Buy Encompass Health (EHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.
EHC or AMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. AMED: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics
by Zacks Equity Research
Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics
3 Top Stocks From the Buoyant Outpatient Home Health Industry
by Trina Mukherjee
Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and USPH are well-poised to gain from the prospects.
Pick These 5 Low P/CF Stocks for a Balanced Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Boise Cascade (BCC), Encompass Health (EHC), Hibbett (HIBB), Celestica (CLS) and Flex Ltd. (FLEX) boast low P/CF ratio.
New Strong Buy Stocks for September 21st
by Zacks Equity Research
CASY, DSKE, EHC, GIII, and STRL have been added to the Zacks Rank #1 (Strong Buy) List on September 21, 2021.
What Makes Encompass Health (EHC) a New Strong Buy Stock
by Zacks Equity Research
Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).